9:15 – 9:45

Findings of the ACP Foundation White Paper on Drug Labeling

Michael Wolf, Ph.D., M.P.H.

Assistant Professor of Preventive Medicine

Feinberg School of Medicine, Northwestern University

9:45 – 10:00

Discussion of Morning Presentations

10:00 – 10:30

Simplification of Drug Dosing Times: Can We Confuse Patients Less? A Proposal for Standardization

Alastair J. J. Wood, M.D., F.A.C.P.

Managing Director

Symphony Capital LLC

10:30 – 11:30

Panel I: Federal Agency Reaction to Prescription Use Instruction Standardization

Cindy Brach, M.P.P.

Senior Health Policy Researcher

Agency for Healthcare Research and Quality

Nancy Ostrove, Ph.D.

Senior Advisor for Risk Communication, Office of Planning, Office of the Commissioner, Food and Drug Administration

Virginia Torrise, Pharm.D.

Deputy Chief Consultant for Pharmacy Benefits Management

Department of Veterans Affairs

11:30 – 12:45

Panel II: Pharmacy Reaction to Prescription Use Instruction Standardization

Alan Goldhammer, Ph.D.

Deputy Vice President, Regulatory Affairs

PhRMA

Darren K. Townzen, R.Ph., M.B.A.

Director of Pharmacy Systems

Wal-Mart

Gerald McEvoy, Pharm.D.

Assistant Vice President of Drug Information

American Society of Health-System Pharmacists

William Ellis, R.Ph., M.S.

Chief Executive Officer

American Pharmacists Association Foundation